Lisica Šikić, N.; Petrić Miše, B.; Tomić, S.; Spagnol, G.; Matak, L.; Juretić, A.; Spagnoli, G.
MAGE-A10 Protein Expression in Advanced High Grade Serous Ovarian Cancer Is Associated with Resistance to First-Line Platinum-Based Chemotherapy. Cancers 2023, 15, 4697.
https://doi.org/10.3390/cancers15194697
AMA Style
Lisica Šikić N, Petrić Miše B, Tomić S, Spagnol G, Matak L, Juretić A, Spagnoli G.
MAGE-A10 Protein Expression in Advanced High Grade Serous Ovarian Cancer Is Associated with Resistance to First-Line Platinum-Based Chemotherapy. Cancers. 2023; 15(19):4697.
https://doi.org/10.3390/cancers15194697
Chicago/Turabian Style
Lisica Šikić, Nataša, Branka Petrić Miše, Snježana Tomić, Giulia Spagnol, Luka Matak, Antonio Juretić, and Giulio Spagnoli.
2023. "MAGE-A10 Protein Expression in Advanced High Grade Serous Ovarian Cancer Is Associated with Resistance to First-Line Platinum-Based Chemotherapy" Cancers 15, no. 19: 4697.
https://doi.org/10.3390/cancers15194697
APA Style
Lisica Šikić, N., Petrić Miše, B., Tomić, S., Spagnol, G., Matak, L., Juretić, A., & Spagnoli, G.
(2023). MAGE-A10 Protein Expression in Advanced High Grade Serous Ovarian Cancer Is Associated with Resistance to First-Line Platinum-Based Chemotherapy. Cancers, 15(19), 4697.
https://doi.org/10.3390/cancers15194697
